345 related articles for article (PubMed ID: 9715278)
1. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.
Maerz WJ; Baselga J; Reuter VE; Mellado B; Myers ML; Bosl GJ; Spinella MJ; Dmitrovsky E
Oncogene; 1998 Aug; 17(6):761-7. PubMed ID: 9715278
[TBL] [Abstract][Full Text] [Related]
2. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells.
Spinella MJ; Kitareewan S; Mellado B; Sekula D; Khoo KS; Dmitrovsky E
Oncogene; 1998 Jul; 16(26):3471-80. PubMed ID: 9692555
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of transforming growth factor alpha antagonizes the anti-tumorigenic but not the differentiation actions of retinoic acid in a human teratocarcinoma cell.
Baselga J; Maerz WJ; Moy D; Miller WH; Castro L; Reuter VE; Yao TJ; Masui H; Dmitrovsky E
Oncogene; 1993 Dec; 8(12):3257-63. PubMed ID: 8247529
[TBL] [Abstract][Full Text] [Related]
4. Derivation and characterization of retinoid-resistant human embryonal carcinoma cells.
Moasser MM; Khoo KS; Maerz WJ; Zelenetz A; Dmitrovsky E
Differentiation; 1996 Jul; 60(4):251-7. PubMed ID: 8765055
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid induces down-regulation of several growth factors and proto-oncogenes in a human embryonal cancer cell line.
Miller WH; Moy D; Li A; Grippo JF; Dmitrovsky E
Oncogene; 1990 Apr; 5(4):511-7. PubMed ID: 2158037
[TBL] [Abstract][Full Text] [Related]
6. Response and resistance to retinoic acid are mediated through the retinoic acid nuclear receptor gamma in human teratocarcinomas.
Moasser MM; DeBlasio A; Dmitrovsky E
Oncogene; 1994 Mar; 9(3):833-40. PubMed ID: 8108126
[TBL] [Abstract][Full Text] [Related]
7. Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1.
Baldassarre G; Romano A; Armenante F; Rambaldi M; Paoletti I; Sandomenico C; Pepe S; Staibano S; Salvatore G; De Rosa G; Persico MG; Viglietto G
Oncogene; 1997 Aug; 15(8):927-36. PubMed ID: 9285688
[TBL] [Abstract][Full Text] [Related]
8. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the retinoic acid receptor gamma directly induces terminal differentiation of human embryonal carcinoma cells.
Moasser MM; Reuter VE; Dmitrovsky E
Oncogene; 1995 Apr; 10(8):1537-43. PubMed ID: 7731708
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid causes a decline in TGF-alpha expression, cloning efficiency, and tumorigenicity in a human embryonal cancer cell line.
Dmitrovsky E; Moy D; Miller WH; Li A; Masui H
Oncogene Res; 1990; 5(3):233-9. PubMed ID: 2320376
[TBL] [Abstract][Full Text] [Related]
11. Regulated expression of Wnt family members during neuroectodermal differentiation of P19 embryonal carcinoma cells: overexpression of Wnt-1 perturbs normal differentiation-specific properties.
Smolich BD; Papkoff J
Dev Biol; 1994 Nov; 166(1):300-10. PubMed ID: 7958454
[TBL] [Abstract][Full Text] [Related]
12. Human Wnt-13 is developmentally regulated during the differentiation of NTERA-2 pluripotent human embryonal carcinoma cells.
Wakeman JA; Walsh J; Andrews PW
Oncogene; 1998 Jul; 17(2):179-86. PubMed ID: 9674702
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27.
Baldassarre G; Boccia A; Bruni P; Sandomenico C; Barone MV; Pepe S; Angrisano T; Belletti B; Motti ML; Fusco A; Viglietto G
Cell Growth Differ; 2000 Oct; 11(10):517-26. PubMed ID: 11063125
[TBL] [Abstract][Full Text] [Related]
14. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T
Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847
[TBL] [Abstract][Full Text] [Related]
15. All-trans-retinoic acid and hexamethylene bisacetamide (HMBA) regulate TGF-alpha and Hst-1/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomas.
Miller WH; Maerz WJ; Kurie J; Moy D; Baselga J; Lucas DA; Grippo JF; Masui H; Dmitrovsky E
Differentiation; 1994 Jan; 55(2):145-52. PubMed ID: 8143931
[TBL] [Abstract][Full Text] [Related]
16. Modulation of differentiation in PA-1 human teratocarcinoma cells after N-ras oncogene-induced tumorigenicity.
Tainsky MA; Yim SO; Krizman DB; Kannan P; Chiao PJ; Mukhopadhyay T; Buettner R
Oncogene; 1991 Sep; 6(9):1575-82. PubMed ID: 1681491
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7).
Andrews PW; Damjanov I; Berends J; Kumpf S; Zappavigna V; Mavilio F; Sampath K
Lab Invest; 1994 Aug; 71(2):243-51. PubMed ID: 7521445
[TBL] [Abstract][Full Text] [Related]
18. Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells.
Chadalavada RS; Korkola JE; Houldsworth J; Olshen AB; Bosl GJ; Studer L; Chaganti RS
Stem Cells; 2007 Mar; 25(3):771-8. PubMed ID: 17138961
[TBL] [Abstract][Full Text] [Related]
19. Response of human rhabdomyosarcoma cell lines to retinoic acid: relationship with induction of differentiation and retinoic acid sensitivity.
Ricaud S; Vernus B; Bonnieu A
Exp Cell Res; 2005 Dec; 311(2):192-204. PubMed ID: 16236281
[TBL] [Abstract][Full Text] [Related]
20. Increased retinoic acid receptor gamma expression suppresses the malignant phenotype and alters the differentiation potential of human neuroblastoma cells.
Marshall GM; Cheung B; Stacey KP; Camacho ML; Simpson AM; Kwan E; Smith S; Haber M; Norris MD
Oncogene; 1995 Aug; 11(3):485-91. PubMed ID: 7630632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
